These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25184591)

  • 1. [Essential medicines and the selection process in management practices of pharmaceutical services in Brazilian states and municipalities].
    Magarinos-Torres R; Pepe VL; Oliveira MA; Osorio-de-Castro CG
    Cien Saude Colet; 2014 Sep; 19(9):3859-68. PubMed ID: 25184591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adherence to essential medicines in cities from three Brazilian states].
    Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
    Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The essentiality and rationality of the Brazilian national listing of essential medicines].
    Yamauti SM; Bonfim JR; Barberato-Filho S; Lopes LC
    Cien Saude Colet; 2017 Mar; 22(3):975-986. PubMed ID: 28301004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of essential medicines in primary health care of the Brazilian Unified Health System.
    Nascimento RCRMD; Álvares J; Guerra AA; Gomes IC; Costa EA; Leite SN; Costa KS; Soeiro OM; Guibu IA; Karnikowski MGO; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):10s. PubMed ID: 29160448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the selection of medicines for the Brazilian primary health care.
    Karnikowski MGO; Galato D; Meiners MMMA; Silva EVD; Gerlack LF; Bós ÂJG; Leite SN; Álvares J; Guibu IA; Soeiro OM; Costa KS; Costa EA; Guerra AA; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):9s. PubMed ID: 29160450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil.
    Figueiredo TA; Schramm JMA; Pepe VLE
    Cad Saude Publica; 2017 Sep; 33(9):e00179815. PubMed ID: 28977283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename).
    Coelho HL; Rey LC; Medeiros MS; Barbosa RA; Cruz Fonseca SG; Costa PQ
    J Pediatr (Rio J); 2013; 89(2):171-8. PubMed ID: 23642428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].
    Yamauti SM; Barberato-Filho S; Lopes LC
    Cad Saude Publica; 2015 Aug; 31(8):1648-62. PubMed ID: 26375644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?
    Osorio-de-Castro CGS; Azeredo TB; Pepe VLE; Lopes LC; Yamauti S; Godman B; Gustafsson LL
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):402-412. PubMed ID: 29117642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.
    Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW
    Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investment of financial resources for the procurement of medicines for primary care in Brazilian municipalities.
    Pontes MA; Tavares NUL; Francisco PMSB; Naves JOS
    Cien Saude Colet; 2017 Aug; 22(8):2453-2462. PubMed ID: 28793063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sources of medicines for chronic patients using the Brazilian Unified National Health System].
    Matta SR; Bertoldi AD; Emmerick ICM; Fontanella AT; Costa KS; Luiza VL;
    Cad Saude Publica; 2018 Mar; 34(3):e00073817. PubMed ID: 29590242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.
    Magarinos-Torres R; Lynd LD; Luz TCB; Marques PEPC; Osorio-de-Castro CGS
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):181-188. PubMed ID: 28371342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of pharmacy interventions in improving availability of essential medicines at the primary healthcare level.
    Nunan M; Duke T
    Trop Med Int Health; 2011 May; 16(5):647-58. PubMed ID: 21342375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Definition of priority medicines for monitoring laboratory quality in Brazil: the interface between health surveillance and the National Drug Policy].
    Pontes Junior DM; Pepe VL; Osorio-de-Castro CG; Massena EP; Portela MC; Miranda Mdo C; Silva RS
    Cad Saude Publica; 2008 Sep; 24(9):2081-90. PubMed ID: 18813684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
    Mahmić-Kaknjo M; Marušić A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Judicialization of medicines: effectiveness of rights or break in public policies?
    Oliveira YMDC; Braga BSF; Farias AD; Pereira SPD; Ferreira MAF
    Rev Saude Publica; 2020; 54():130. PubMed ID: 33331524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pharmaceutical services in the Brazilian primary health care.
    Gerlack LF; Karnikowski MGO; Areda CA; Galato D; Oliveira AG; Álvares J; Leite SN; Costa EA; Guibu IA; Soeiro OM; Costa KS; Guerra AA; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):15s. PubMed ID: 29160449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare essentials: drugs for rare diseases as essential medicines.
    Stolk P; Willemen MJ; Leufkens HG
    Bull World Health Organ; 2006 Sep; 84(9):745-51. PubMed ID: 17128345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.